ANLONG
Latest round
- Series B
Last raised
- Jan 2026
Total raised
- $20M
Investors
- 11
About ANLONG
, trading as ANLONG, operas as a gene therapy company which focuses on ophthalmology. The company has a 5000 square meter R&D and GMP production base in zhongguancun medical transformation center. The founder and CEO, Zhao Chunlin, has more than 30 years entrepreneurship and investment experience in the field of scientific research, multinational pharmaceutical companies, domestic pharmaceuticals and medical instrument. ANLONG focuses on nucleic acid drugs, include gene therapy, gene editing, RNA drugs, oncolytic viruses and other new drug development technology. Besides, the company focuses on gene therapy of wet macular degeneration wAMD and AAV vector screening. The company mainly focuses on the field of ophthalmology, blood, neuromuscular system and cardio-cerebrovascular system. The company generates revenue by developing new drugs using technologies such as gene regulation, gene therapy, and gene editing.
Who invested in ANLONG
11 investors across 4 rounds
See all investors in ANLONG
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about ANLONG
Who invested in ANLONG?
ANLONG has 11 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ANLONG raised?
ANLONG has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did ANLONG last raise money?
ANLONG's most recent round on record is a Series B, in Jan 2026.
What does ANLONG do?
, trading as ANLONG, operas as a gene therapy company which focuses on ophthalmology.
Where is ANLONG headquartered?
ANLONG is headquartered in Beijing, China.
Which VCs invest in companies like ANLONG?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at ANLONG's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like ANLONG? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.